Φορτώνει......
Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies
Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide with an overall survival rate of less than 15% in developed countries. Despite attempts at new therapeutic strategies, the majority of patients succumb to this cancer. Buttressed by the highly successful clinical impact in me...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Lett |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5496242/ https://ncbi.nlm.nih.gov/pubmed/28428075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2017.04.013 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|